ES2326324T3 - Me-5, me-2 y epp2: antigenos de proteina humana reactivos con anticuerpos presentes en el suero de mujeres que padecen de endometriosis. - Google Patents

Me-5, me-2 y epp2: antigenos de proteina humana reactivos con anticuerpos presentes en el suero de mujeres que padecen de endometriosis. Download PDF

Info

Publication number
ES2326324T3
ES2326324T3 ES05254121T ES05254121T ES2326324T3 ES 2326324 T3 ES2326324 T3 ES 2326324T3 ES 05254121 T ES05254121 T ES 05254121T ES 05254121 T ES05254121 T ES 05254121T ES 2326324 T3 ES2326324 T3 ES 2326324T3
Authority
ES
Spain
Prior art keywords
endometriosis
epp2
protein
patients
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05254121T
Other languages
English (en)
Spanish (es)
Inventor
A Said El Shami
Bruce Campbell
Dennis Sustarsic
Niver Sahakian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Application granted granted Critical
Publication of ES2326324T3 publication Critical patent/ES2326324T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
ES05254121T 2004-07-07 2005-06-30 Me-5, me-2 y epp2: antigenos de proteina humana reactivos con anticuerpos presentes en el suero de mujeres que padecen de endometriosis. Expired - Lifetime ES2326324T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/887,540 US20060008876A1 (en) 2004-07-07 2004-07-07 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
US887540 2004-07-07

Publications (1)

Publication Number Publication Date
ES2326324T3 true ES2326324T3 (es) 2009-10-07

Family

ID=35124497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05254121T Expired - Lifetime ES2326324T3 (es) 2004-07-07 2005-06-30 Me-5, me-2 y epp2: antigenos de proteina humana reactivos con anticuerpos presentes en el suero de mujeres que padecen de endometriosis.

Country Status (9)

Country Link
US (7) US20060008876A1 (enExample)
EP (1) EP1614692B1 (enExample)
JP (1) JP2006051019A (enExample)
AT (1) ATE433462T1 (enExample)
AU (1) AU2005202925A1 (enExample)
CA (1) CA2509632A1 (enExample)
DE (1) DE602005014828D1 (enExample)
ES (1) ES2326324T3 (enExample)
NZ (1) NZ541063A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329399B2 (en) * 2006-10-27 2012-12-11 Siu K W Michael Endometrial biomarkers
US8279789B2 (en) * 2008-06-10 2012-10-02 Qualcomm Incorporated Intelligent setting of hysteresis activation timer to enter hysteresis sooner and save battery
WO2011085213A2 (en) * 2010-01-07 2011-07-14 Sanford-Burnham Medical Research Institute Pathologically-activated therapeutics
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
GB202310300D0 (en) 2023-07-05 2023-08-16 Univ Edinburgh Endometrosis markers and methods of diagnosing nedometriosis

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US652187A (en) * 1899-11-02 1900-06-19 Sigvald Krohn System of electrical distribution.
US4489166A (en) * 1982-05-27 1984-12-18 Research Corporation Monitoring of human endometrial function by radioimmunoassay of PEP
AU5068090A (en) 1989-03-07 1990-09-13 Adeza Biomedical Corporation Endometriosis diagnosis methods and reagents
US5302738A (en) 1991-03-15 1994-04-12 Hoffmann-La Roche Inc. Chiral phosphines
CA2062675A1 (en) 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
US5877284A (en) * 1993-08-12 1999-03-02 The Trustees Of The University Of Pennsylvania Isolated chemotactic factor from patients with endometriosis
US7122322B2 (en) * 1994-10-25 2006-10-17 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US6531277B2 (en) * 1994-10-25 2003-03-11 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis
US5618680A (en) * 1994-12-28 1997-04-08 Institut De Medecine De La Reproduction De Montreal Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
US6376201B2 (en) * 1994-12-28 2002-04-23 Procrea Biosciences Inc. Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
WO1997035016A1 (en) 1996-03-18 1997-09-25 Novo Nordisk Biotech Inc Polypeptides having phytase activity and nucleic acids encoding same
WO1997035018A1 (en) 1996-03-21 1997-09-25 New York University Growth factor inducible serine/threonine phosphatase fin13
US6294662B1 (en) * 1996-08-27 2001-09-25 University Of South Florida Nucleic acids encoding an endometrial bleeding associated factor (ebaf)
WO1999004265A2 (en) 1997-07-17 1999-01-28 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
US6165767A (en) * 1998-03-20 2000-12-26 Incyte Pharmaceuticals, Inc. Protein phosphatase-related molecules
AU760613B2 (en) 1998-06-04 2003-05-22 Reprogen, Inc. Use of prothymosin in the diagnosis and treatment of endometriosis
AU765750B2 (en) * 1998-06-04 2003-09-25 Reprogen, Inc. Use of cathepsin s in the diagnosis and treatment of endometriosis
US6525187B1 (en) * 1998-07-31 2003-02-25 Diagnostic Products Corporation Polynucleotide encoding autoantigens associated with endometriosis
ATE374370T1 (de) 1999-01-25 2007-10-15 Siemens Medical Solutions Diag Verfahren zur diagnose von endometriose
WO2000059547A2 (en) * 1999-04-02 2000-10-12 Center For Molecular Medicine And Immunology Method of detecting endometriosis
WO2000063675A1 (en) 1999-04-16 2000-10-26 Bioincept, Inc. Identification of a serum marker for endometriosis
WO2000075321A2 (en) * 1999-06-03 2000-12-14 Curagen Corporation Polynucleotides and membrane-bound polypeptide encoded thereby
EP1238104A2 (en) 1999-11-03 2002-09-11 Metris Therapeutics Limited Agents implicated in endometriosis
GB0004232D0 (en) 2000-02-24 2000-04-12 Zeneca Ltd Diagnostic method
ES2336817T3 (es) * 2000-02-25 2010-04-16 Siemens Healthcare Diagnostics Inc. Marcadores relacionados con la endometriosis y usos de los mismos.
JP2003532078A (ja) * 2000-04-19 2003-10-28 リサーチ コーポレイション テクノロジーズ，インコーポレイテッド 子宮内膜症の診断アッセイ
WO2001079846A2 (en) * 2000-04-19 2001-10-25 Research Corporation Technologies, Inc. Diagnostic assay for endometriosis
DE10048633A1 (de) 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
US6780594B2 (en) * 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
WO2002068579A2 (en) 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
AU2002320630A1 (en) * 2001-07-17 2003-03-03 University Of Florida Detecting and treating reproductive tract disorders
AU2003295328A1 (en) * 2002-10-02 2004-04-23 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004087874A2 (en) 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US6843673B1 (en) * 2004-04-30 2005-01-18 Speed Tech Corp. Coaxial connector structure

Also Published As

Publication number Publication date
US20060008876A1 (en) 2006-01-12
US20100062453A1 (en) 2010-03-11
US8030007B2 (en) 2011-10-04
AU2005202925A1 (en) 2006-02-02
EP1614692A2 (en) 2006-01-11
US20070141600A1 (en) 2007-06-21
US7879562B2 (en) 2011-02-01
EP1614692A3 (en) 2006-04-05
NZ541063A (en) 2008-07-31
CA2509632A1 (en) 2006-01-07
US20080153106A1 (en) 2008-06-26
ATE433462T1 (de) 2009-06-15
US20070178528A1 (en) 2007-08-02
DE602005014828D1 (de) 2009-07-23
US20110201129A1 (en) 2011-08-18
US7981626B2 (en) 2011-07-19
US20100330696A1 (en) 2010-12-30
EP1614692B1 (en) 2009-06-10
JP2006051019A (ja) 2006-02-23

Similar Documents

Publication Publication Date Title
ES2324767T3 (es) Marcador para estados inflamatorios.
Volkmann et al. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis
ES2260756T3 (es) Proteina y peptidos alergenicos de caspa de perro y sus usos.
JP4794102B2 (ja) フィブリンのシトルリン誘導体及び慢性関節リウマチの診断又は治療のためのその使用
AU684577B2 (en) Chaperonin 10
US8030007B2 (en) Method for the detection of endometriosis using an ME-2 antigen
KR0174528B1 (ko) 암과 관련된 헵토글로빈
ES2411921T3 (es) Uso de HE4 para la evaluación de cánceres de mama
JPH04504119A (ja) ブタクサからのアレルゲン蛋白質およびそれらの使用
Naz Search for peptide sequences involved in human antisperm antibody‐mediated male immunoinfertility by using phage display technology
JP2002504330A (ja) 組換え型活性ヒト透明帯タンパク質３（ｈＺＰ３）
ES2376167T3 (es) Inmunoensayos para la determinación espec�?fica de isoformas de scca.
JP5156997B2 (ja) Ｉｖ型コラーゲン様免疫活性ペプチド
Schumann et al. A child with localized vulval pemphigoid and IgG autoantibodies targeting the C‐terminus of collagen XVII/BP180
JP3455782B2 (ja) 強皮症の診断薬
ES2355265T3 (es) Un kit para detección inmunologica de nuroglobulina ligada a enzima y uso del mismo.
Bell et al. Development and Validation of a radioimmunoassay for human secretory ‘pregnancy-associated endometrial α2-globulin’(α2-PEG) and detection in serum during pregnancy
Laurie et al. Immunological and partial sequence identity of mouse BM180 with wheat α-gliadin
JP5311117B2 (ja) 免疫細胞刺激活性を有する機能ペプチド
KR102307043B1 (ko) Wasf2 자가항체를 이용한 간세포암종 조기진단용 조성물
KR101568457B1 (ko) ＧｒｏＥＬ을 포함하는 베체트병 진단용 키트
Naz et al. Autoantigenicity of human sperm: molecular identities of sperm antigens recognized by sera of immunoinfertile men in the immunoprecipitation procedure
Szabó Pregnancy-Related Protein Concentrations During Normal Pregnancy
CN103649327B (zh) 用以检测子宫内膜异位的专一性a1at单克隆抗体
CN110865184A (zh) Srsp蛋白和srsp抗原表位肽的应用及诊断和治疗肿瘤的产品